Exosome Component 9 (EXOSC9) (N-Term) Peptide
EXOSC9
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all EXOSC9 products
- EXOSC9 (Exosome Component 9 (EXOSC9))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- ERRFLLRAIE EKKRLDGRQT YDYRNIRISF GTDYGCCIVE LGKTRVLGQV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-EXOSC9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
Exosome Component 9 (EXOSC9) peptide
EXOSC9 Reactivity: Human Host: Synthetic BP, Imm
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EXOSC9 (Exosome Component 9 (EXOSC9))
- Synonyms
- scl75 Peptide, im:6909054 Peptide, zgc:101680 Peptide, PM/Scl-75 Peptide, PMSCL1 Peptide, RRP45 Peptide, Rrp45p Peptide, p5 Peptide, p6 Peptide, Pmscl1 Peptide, exosome component 9 L homeolog Peptide, exosome component 9 Peptide, exosc9.L Peptide, exosc9 Peptide, EXOSC9 Peptide, Exosc9 Peptide
- Background
-
EXOSC9 is a non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC9 binds to ARE-containing RNAs.
Alias Symbols: PM/Scl-75, PMSCL1, RRP45, Rrp45p, p5, p6
Protein Interaction Partner: EXOSC4,EXOSC1,DDX39A,DDX39B,DIS3,EXOSC1,EXOSC2,EXOSC3,EXOSC4,EXOSC5,EXOSC6,EXOSC7,EXOSC8,EXOSC9,MPP6,SKIV2L2,SUMO2,UBE2I
Protein Size: 355 - Molecular Weight
- 39 kDa
- Gene ID
- 5393
- NCBI Accession
- NM_005033, NP_005024
- UniProt
- Q06265
-
You are here:
